New recombinant raw ingredients developed for use in large-scale mammalian cell culture are becoming readily available.
May 2, 2007
By:
Sara Mortellaro, Maree Devine
In addition to existing guidance, in January 2007 the FDA announced further proposals to prohibit the use of certain bovine materials as ingredients in some medical products or as elements of product manufacturing.
|